Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung CancerHongge Liang, Mengzhao Wang, Yan Xu et al.|Frontiers in Immunology|2022Cited by 34
Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observational studyHongge Liang, Mengzhao Wang, Fang Li et al.|Thoracic Cancer|2019Cited by 26
Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteriaHongge Liang, Jing Zhao, Yan Xu et al.|Thoracic Cancer|2020Cited by 24
Prognostic impact of maximum standardized uptake value on <scp><sup>18</sup>F‐FDG PET</scp>/<scp>CT</scp> imaging of the primary lung lesion on survival in advanced non‐small cell lung cancer: A retrospective studyXiaoling Qiu, Mengzhao Wang, Hongge Liang et al.|Thoracic Cancer|2021Cited by 16
Clinicopathological characteristics of lung cancer in patients with systemic sclerosisMinjiang Chen, Mengzhao Wang, Xiaoyan Liu et al.|The Clinical Respiratory Journal|2020Cited by 10